BPC-157
10 mg vial, 60 capsules
Glutathione supplements Australia pharmacies stock come in four main shapes, swallowed tablets or capsules, liposomal liquids, sublingual tablets, and precursor products built on NAC. Here they are classed as listed medicines, while Europe sells the same kinds of product as food supplements. Trials still argue over how much of an oral dose makes it past digestion. One point up front. AminoLab is not a supplement retailer, and the single glutathione item we carry is a 1,500 mg research vial of reduced glutathione for laboratory work.
Nothing in the AminoLab catalogue is meant for swallowing. That rules out glutathione tablets, pills, capsules and liposomal liquids alike. Our one listing is a lyophilized vial of reduced L-glutathione, packed for bench chemistry. Because people hunting for a supplement regularly arrive at research supply shops, we would rather spell it out now. A reagent vial is built for a lab buyer, and a supplement is built for a consumer. They are not interchangeable.
The rest of this page walks through each supplement format, summarises the absorption trials in our own words, and then explains why a lab would want a reagent instead. You will not find a brand pick or a dose suggestion anywhere here. Readers who want the biochemistry first can start with our explainer on what glutathione is.
Glutathione is a three amino acid peptide, glutamate plus cysteine plus glycine, and your cells synthesise it continuously. Products on the market approach it from four directions.
The label wording glutathione food supplement is largely a European import. Under EU Directive 2002/46/EC, a food supplement is a foodstuff that tops up the normal diet, delivered in measured units such as capsules, pills, tablets or dosed liquids, and acting as a concentrated source of nutrients or of other substances that carry a nutritional or physiological effect. Australia sorts most of these goods into a different legal box, which we cover in the regulation section.
Peptides rarely have an easy ride through the intestine. Brush border enzymes, gamma-glutamyltransferase chief among them, chop them into single amino acids, and glutathione is no exception. Three oral trials frame the debate.
So short exposures show almost nothing, while a long, well designed trial showed a slow climb in stores that vanished on stopping. Whether intact GSH is getting across, or whether the body is simply recycling the released amino acids into new glutathione, is a question these data leave open.
Sublingual GSH has exactly one comparison study behind it. In Redox Biology in 2015, Schmitt et al. enrolled 20 adults with metabolic syndrome in a crossover lasting three weeks per arm. Each person rotated through 450 mg a day swallowed, 450 mg a day held under the tongue, and NAC at 200 mg a day. Sublingual delivery lifted reduced and total plasma glutathione significantly further than swallowing did, and the swallowed tablet in fact drifted slightly down, though not significantly. The sublingual arm also ended with the most favourable GSH to GSSG ratio of the three.
Liposomal products are sold as the workaround for poor uptake. In humans, that promise rests on one pilot. Sinha et al., writing in the European Journal of Clinical Nutrition in 2018 (again a Penn State group), gave a dozen healthy adults 500 mg or 1,000 mg of liposomal glutathione daily for one month. Rises showed up inside the first week. The two week peaks were 100% in peripheral blood mononuclear cells, 40% in whole blood, 28% in plasma and 25% in erythrocytes. Natural killer cell cytotoxicity went up by as much as 400%, and plasma 8-isoprostane, which tracks oxidative stress, came down 35%.
Most talk of liposomal glutathione benefits traces straight back to that paper, which makes its weaknesses important. Twelve participants. Four weeks. No placebo arm reported in the abstract. And the two dose groups did not differ, with the authors themselves flagging low statistical power. Our take is that liposomal delivery is a plausible approach with a hopeful pilot, but it has not been shown to beat ordinary tablets, and no trial among those cited here tested the two against each other.
The precursor strategy never puts glutathione in the capsule at all. It feeds the synthesis pathway instead. Cysteine tends to be the scarce input, so NAC, a stable way of delivering cysteine, is the traditional choice.
The paper most often cited is Sekhar et al., 2011, in the American Journal of Clinical Nutrition. Stable isotope infusions revealed that people aged 60 to 75 carried less red cell glutathione and made it more slowly than a younger comparison group. Eight of the older volunteers were then given glycine together with cysteine, in the form of N-acetylcysteine, for 14 days. Red cell GSH concentration rose 94.6%. Fractional synthesis climbed 78.8%. Absolute synthesis jumped 230.9%. Oxidative stress markers in plasma dropped to around the young group's levels.
Two limits apply. Eight treated people is a very small sample, and the volunteers were chosen because they were measurably low. Nothing here shows that precursors raise glutathione in healthy younger people whose production is already adequate. Recall too that NAC at 200 mg daily did not outdo sublingual glutathione in the Schmitt crossover.
| Product type | Active content | Trial cited | Outcome | Main caveat |
|---|---|---|---|---|
| Tablets, capsules, pills | Reduced L-glutathione | Richie et al., 2015; Allen and Bradley, 2011 | Stores climbed over six months in one study, flat after four weeks in the other | Digested by intestinal enzymes, gains lost once intake ends |
| Liposomal | GSH sealed in phospholipid spheres | Sinha et al., 2018 | Higher GSH in blood and immune cells by week two | A dozen people for a month, placebo arm not described |
| Sublingual | GSH tablet dissolved under the tongue | Schmitt et al., 2015 | Bigger plasma GSH gain than the swallowed tablet | Only 20 people, three weeks for each arm |
| Precursors | NAC (N-acetylcysteine) and glycine | Sekhar et al., 2011 | Older adults recovered synthesis and red cell GSH | Eight treated people, all with low baseline levels |
| Research vial (not a supplement) | Freeze-dried reduced glutathione | Lab use only | Each lot has a documented mass and purity | Never for human consumption |
Route matters for safety as well. Nebulised and injected glutathione carry risks that swallowed products do not, and our review of glutathione side effects covers each in turn.
A glutathione supplement sold here counts as a therapeutic good. Nearly all of them are listed medicines, the bottom risk tier, and you can spot them by the AUST L code printed on the box. The TGA's own explanation of that tier repays a close read.
A search of the ARTG on the TGA website, run while this guide was being written, listed numerous glutathione products from a range of sponsors, among them sublingual tablets and liposomal liquids. That is why the choice of liposomal glutathione in Australia is so broad on pharmacy shelves. Keep in mind that AUST L only means the product may be legally supplied. It is not a TGA verdict on effectiveness. Skin whitening claims are off limits for listed medicines too, as discussed in what the glutathione skin studies found. Personal questions about taking any supplement belong with your pharmacist or GP.
Few reagents turn up in redox biology as often as reduced glutathione. Cell culture groups add it as an antioxidant control when they model oxidative stress. Enzymologists feed it to glutathione peroxidase and glutathione S-transferase assays as substrate. Protein chemists include it in refolding buffers as a reducing agent. Every one of those uses needs a weighed, identity-confirmed quantity of GSH, which a supplement capsule with fillers, flow agents and lipid coating cannot provide.
Because 1,500 mg is a lot of powder, our 1,500 mg reduced glutathione vial uses a 10 mL vial. Every lot goes to an independent laboratory, where HPLC checks purity and mass spectrometry checks identity. Match the lot number on your vial to its report in the certificate of analysis lookup, and if the format is new to you, our guide to reading a COA line by line shows what a clean result should contain. Unopened vials go in the freezer at minus 20 °C. GSH in solution oxidises over time into GSSG, so keep made-up solutions cold and use them quickly. The peptide storage guide has the detail.
Many oxidative stress designs run glutathione next to mitochondrial reagents, NAD+ and the SS-31 peptide being common partners. Browse the full set under mitochondrial research compounds.
Price per milligram settles the capsule versus vial question for most labs. Order the AminoLab glutathione vial online, dispatched from stock held in Australia, confirm its COA, and dissolve only the amount a given run requires. Teams running antioxidant comparisons often pick up NAD+ as well for redox and sirtuin experiments, and related compounds sit in the longevity research range. Supplements, tablets and liposomal drinks are simply not part of what we do. Buy from us for the bench, and only for the bench.
Sale is restricted to adults 18+ and to laboratory research use only. This glutathione is non-sterile, is not a supplement, and is not intended for human or veterinary use. Turning it into capsules, beverages or anything else meant for consumption is not permitted.
We cannot name the best glutathione supplement, since AminoLab sells none and backs no brand or dose. The trials offer pointers only. Long-term plain tablets nudged stores up over six months in one study, small liposomal and sublingual trials were positive, and NAC with glycine helped older adults rebuild synthesis. Look for an AUST L code on the pack and ask your pharmacist.
Nobody has shown liposomal to be superior. Sinha's 2018 pilot recorded blood glutathione up as much as 40% in a fortnight, but with twelve people, one month of follow-up and no reported placebo. No published trial we know of pits liposomal against plain oral glutathione, so claims that it wins are ahead of the data.
Evidence points both ways. A 1992 single-dose study and a 2011 four-week trial saw no meaningful increase, largely because intestinal enzymes digest the peptide. In a 2015 six-month trial, 1,000 mg a day lifted blood compartment stores 30 to 35%, and those gains were gone a month after people stopped.
No. Our range contains no tablets, pills, capsules, liposomal liquids or supplements of any description. The only glutathione item is a 1,500 mg lyophilized vial of reduced L-glutathione for laboratory research, with identity and purity confirmed and a certificate matched to the lot. It is not for human consumption.
Mostly biomarkers. Controlled studies tracked glutathione levels and oxidative stress markers rather than clinical outcomes. Richie's six-month trial found larger body stores and natural killer cell activity more than doubled at month three. Broader health benefits are poorly supported, and listed medicines in Australia may only use low-level permitted claims.
Right here. AminoLab ships reduced L-glutathione as a 1,500 mg lyophilised vial from Australian stock, for laboratory use only. Independent testing of every lot confirms identity by mass spectrometry and purity by HPLC. It is a reagent, so it must not be converted into any consumable product.
10 mg vial, 60 capsules
50 mg vial, 100 mg vial
10 mg vial
3 mL, 3 mL + 1 syringe, 10 mL, 10 mL + 1 syringe, 30 mL, 30 mL + 1 syringe
Research use onlyAminoLab supplies research compounds for laboratory and in-vitro use, not for human or animal consumption. By continuing you confirm you are 18 or older and buying for research.
Leave